Gene Expression Market Key Vendors Research Report to 2021 Aug-2017

New growth report on Global Gene Expression Market 2017-2021 report is
includes on RnRMarketResearch.com.
The analysts forecast global gene expression market to grow at a CAGR of 10.56%
during the period 2017-2021. Gene expression functions as a key pillar of the molecular
biology market as multiple molecular biology techniques have been used extensively to
study gene expression and gene quantification. Molecular biology techniques such as
polymerase chain reaction (PCR); nucleotide sequencing, including next-generation
sequencing (NGS); and microarray analysis are the techniques pivotal for the success of
a gene expression study. These advancements have contributed to the overall growth of
the molecular biology market.
Complete report available on http://www.rnrmarketresearch.com/global-gene-
expression-market-2017-2021-market-report.html .
This report covers the present scenario and the growth prospects of the global gene
expression market for 2017-2021. To calculate the market size, the report considers the
revenue generated from the retail sales of instruments and consumables used to analyze
gene expression.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Get sample copy of report @ http://www.rnrmarketresearch.com/contacts/request-
sample?rname=1176255 .
This report, Global Gene Expression Market 2017-2021, has been prepared based on an
in-depth market analysis with inputs from industry experts. The report covers the
market landscape and its growth prospects over the coming years. The report also
includes a discussion of the key vendors operating in this market.
Key vendors: Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche and
thermo Fisher Scientific
Inquire for Discount on the Report at
http://www.rnrmarketresearch.com/contacts/discount?rname=1176255 .
Other prominent vendors: Fluidigm, GE Healthcare Dharmacon, Illumina, Interpace
Diagnostics, Miltenyi Biotec, New England BioLabs, OriGene Technologies, Oxford
Nanopore Technologies, PerkinElmer, Phalanx Biotech Group, Promega, QIAGEN and
Zyagen
Market driver: Decreasing cost of DNA sequencing and for a full, detailed list, view our
report
Market challenge: Shortage of trained healthcare professionals in genomics and for a
full, detailed list, view our report
Market trend: Emergence of advanced genome editing techniques and genetic
screening programs and for a full, detailed list, view our report